In both the UK and throughout Europe, more patients are presenting with renal cell cancer (RCC), also known as renal cell carcinoma or kidney cancer.
The overall survival rate varies depending on tumour grade, nodal involvement and metastasis. For those with metastasis survival drops to 10%. This article explores the risk factors associated with RCC diagnosis and staging, treatments including drugs and procedures and the role of the nurse in diagnosis and accurate assessment. Nurses are ideally suited to consider the physical, functional, social, and emotional status of their patients In addition, it is essential that the nurse has an understanding of new pharmaceutical therapies, which have been licensed to treat RCC, and a sound knowledge of the possible side effects and nursing management associated with these drugs.
Written by:
Noble H, Page K. Are you the author?
School of Nursing and Midwifery, Queens University Belfast.
Reference: Br J Nurs. 2012 Sep 27-Oct 10;21(17):S18, S20-2.
PubMed Abstract
PMID: 23123694
UroToday.com Renal Cancer Section
